Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Atavistik Bio, Inc
Centre Oscar Lambret
Abramson Cancer Center at Penn Medicine
Pfizer
AstraZeneca
M.D. Anderson Cancer Center
AstraZeneca
Genmab
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
University of Alabama at Birmingham
Rutgers, The State University of New Jersey
National Institutes of Health Clinical Center (CC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Yuri Semenyuk Rivne Regional Clinical Hospital
Washington University School of Medicine
University Health Network, Toronto
Icahn School of Medicine at Mount Sinai
Dana-Farber Cancer Institute
Stanford University
University of Virginia
University of California, San Diego
Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Washington University School of Medicine
Northwell Health
Jonsson Comprehensive Cancer Center
Incyte Corporation
Leap Therapeutics, Inc.
University of Alabama at Birmingham
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Abramson Cancer Center at Penn Medicine
University of Alabama at Birmingham
Northwestern University
Precision Biologics, Inc
Revolution Medicines, Inc.
Elevation Oncology
Northwestern University
UNC Lineberger Comprehensive Cancer Center
Indiana University
Karyopharm Therapeutics Inc
Karolinska Institutet
Memorial Sloan Kettering Cancer Center
Northwestern University
Mabwell (Shanghai) Bioscience Co., Ltd.
Massachusetts General Hospital
University of California, Irvine
Cedars-Sinai Medical Center
Advaxis, Inc.
Universitair Ziekenhuis Brussel